Alphagan patent ruling
Executive Summary
Allergan's lawsuit for induced infringement against Alcon and Bausch & Lomb was properly dismissed because the two companies' ANDAs for brimonidine did not seek FDA approval for uses claimed in two Allergan patents, U.S. appeals court rules March 28 (1"The Pink Sheet" Jan. 27, p. 18)...
You may also be interested in...
Neurontin Bulk Supply May Limit Generic Uptake, Pfizer Says
Neurontin generics will have to overcome limitations in the bulk drug supply in addition to Pfizer's patent defenses, Pfizer CEO Henry McKinnell told a Jan. 22 earnings conference call
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.